Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.
Woei-A-Jin FJSH, Van Nieuwenhuyse T, van Erp NP, Beuselinck B, Stroobants S, Moes DJAR, Osanto S, Spriet I.
Woei-A-Jin FJSH, et al. Among authors: osanto s.
J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6.
J Clin Oncol. 2018.
PMID: 30188790
No abstract available.